Phibro Animal Health (PAHC) Net Cash Flow (2013 - 2026)

Phibro Animal Health's Net Cash Flow history runs 14 years deep, the most recent figure standing at -$2.9 million for Q1 2026.

• On a quarterly basis, Net Cash Flow rose 60.38% year-over-year to -$2.9 million in Q1 2026; TTM through Mar 2026 was -$8.6 million, a 165.27% decrease from a year earlier, with the FY2025 full-year figure at -$1.4 million, down 104.38% from the prior year.
• Net Cash Flow improved to -$2.9 million in Q1 2026 per PAHC's latest filing, from -$16.8 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $21.1 million in Q2 2024 and bottomed at -$31.2 million in Q1 2023.
• The 5-year median for Net Cash Flow is $2.5 million (2022), against an average of -$396000.0.
• Across the five-year window, Net Cash Flow jumped 755.51% in 2022 and plunged 1010.17% in 2024, its largest moves.
• Year by year, Net Cash Flow stood at -$8.6 million in 2022, then rose by 6.7% to -$8.0 million in 2023, then soared by 336.3% to $18.9 million in 2024, then slumped by 188.84% to -$16.8 million in 2025, then surged by 82.75% to -$2.9 million in 2026.
• Per Business Quant, the three latest PAHC Net Cash Flow figures stand at -$2.9 million (Q1 2026), -$16.8 million (Q4 2025), and $4.6 million (Q3 2025).